A multicenter retrospective observational cohort study of letermovir in adult cytomegalovirus seropositive allogeneic hematopoietic stem cell transplant recipients
Latest Information Update: 03 Feb 2023
At a glance
- Drugs Letermovir (Primary) ; Letermovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
Most Recent Events
- 03 Feb 2023 New trial record